{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:32:59Z","timestamp":1793748779220,"version":"4.6.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1220704"],"award-info":[{"award-number":["1220704"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1200308"],"award-info":[{"award-number":["1200308"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["3200677"],"award-info":[{"award-number":["3200677"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a rare inherited skin disease caused by variants in the\n                      <jats:italic>COL7A1<\/jats:italic>\n                      gene, coding for type VII collagen (C7), an important component of anchoring fibrils in the basement membrane of the epidermis. RDEB patients suffer from skin fragility starting with blister formation and evolving into chronic wounds, inflammation and skin fibrosis, with a high risk of developing aggressive skin carcinomas. Restricted therapeutic options are limited by the lack of in vitro models of defective wound healing in RDEB patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In order to explore a more efficient, non-invasive in vitro model for RDEB studies, we obtained patient fibroblasts derived from discarded dressings) and examined their phenotypic features compared with fibroblasts derived from non-injured skin of RDEB and healthy-donor skin biopsies. Our results demonstrate that fibroblasts derived from RDEB chronic wounds (RDEB-CW) displayed characteristics of senescent cells, increased myofibroblast differentiation, and augmented levels of TGF-\u03b21 signaling components compared to fibroblasts derived from RDEB acute wounds and unaffected RDEB skin as well as skin from healthy-donors. Furthermore, RDEB-CW fibroblasts exhibited an increased pattern of inflammatory cytokine secretion (IL-1\u03b2 and IL-6) when compared with RDEB and control fibroblasts. Interestingly, these aberrant patterns were found specifically in RDEB-CW fibroblasts independent of the culturing method, since fibroblasts obtained from dressing of acute wounds displayed a phenotype more similar to fibroblasts obtained from RDEB normal skin biopsies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results show that in vitro cultured RDEB-CW fibroblasts maintain distinctive cellular and molecular characteristics resembling the inflammatory and fibrotic microenvironment observed in RDEB patients\u2019 chronic wounds. This work describes a novel, non-invasive and painless strategy to obtain human fibroblasts chronically subjected to an inflammatory and fibrotic environment, supporting their use as an accessible model for in vitro studies of RDEB wound healing pathogenesis. As such, this approach is well suited to testing new therapeutic strategies under controlled laboratory conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40659-023-00437-2","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T04:41:20Z","timestamp":1683693680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Maintenance of chronicity signatures in fibroblasts isolated from recessive dystrophic epidermolysis bullosa chronic wound dressings under culture conditions"],"prefix":"10.1186","volume":"56","author":[{"given":"Cristian","family":"De Gregorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyng","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Morand\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimena Castillo","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda","family":"Cofr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Cuadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Murgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Altermatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Joao","family":"Yubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Palisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"South","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2064-3041","authenticated-orcid":false,"given":"Marcelo","family":"Ezquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacia","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"437_CR1","doi-asserted-by":"publisher","unstructured":"Bardhan A, Bruckner-Tuderman L, Chapple ILC, Fine JD, Harper N, Has C, \u2026, Heagerty AH. Epidermolysis bullosa. Nat Reviews Disease Primers. 2020;6(1). https:\/\/doi.org\/10.1038\/s41572-020-0210-0.","DOI":"10.1038\/s41572-020-0210-0"},{"issue":"6","key":"437_CR2","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","volume":"70","author":"JD Fine","year":"2014","unstructured":"Fine JD, Bruckner-Tuderman L, Eady RAJ, Bauer EA, Bauer JW, Has C, \u2026, Zambruno G. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70(6):1103\u201326. https:\/\/doi.org\/10.1016\/j.jaad.2014.01.903.","journal-title":"J Am Acad Dermatol"},{"key":"437_CR3","doi-asserted-by":"publisher","unstructured":"Has C, Bauer JW, Bodemer C, Bolling MC, Bruckner-Tuderman L, Diem A, \u2026, Mellerio JE. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol. 2020;1\u201314. https:\/\/doi.org\/10.1111\/bjd.18921.","DOI":"10.1111\/bjd.18921"},{"key":"437_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2017.01.002","volume":"63","author":"L Guerra","year":"2017","unstructured":"Guerra L, Odorisio T, Zambruno G, Castiglia D. Stromal microenvironment in type VII collagen-deficient skin: the ground for squamous cell carcinoma development. Matrix Biol. 2017;63:1\u201310. https:\/\/doi.org\/10.1016\/j.matbio.2017.01.002.","journal-title":"Matrix Biol"},{"issue":"22","key":"437_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20225707","volume":"20","author":"AG Condorelli","year":"2019","unstructured":"Condorelli AG, Dellambra E, Logli E, Zambruno G, Castiglia D. Epidermolysis bullosa-associated squamous cell carcinoma: from pathogenesis to therapeutic perspectives. Int J Mol Sci. 2019;20(22):1\u201328. https:\/\/doi.org\/10.3390\/ijms20225707.","journal-title":"Int J Mol Sci"},{"key":"437_CR6","doi-asserted-by":"crossref","unstructured":"Shinkuma S. (2015). Dystrophic epidermolysis bullosa: a review. Clin Cosmet Investig Dermatol. 26;8: 275\u2013284. https:\/\/doi.org\/10.2147%2FCCID.S54681.","DOI":"10.2147\/CCID.S54681"},{"key":"437_CR7","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","volume":"72","author":"Y-Z Ng","year":"2012","unstructured":"Ng Y-Z, Pourreyron C, Salas-Alanis JC, Dayal JHS, Cepeda-Valdes R, Yan W, et al. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res. 2012;72:3522\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-2996.","journal-title":"Cancer Res"},{"key":"437_CR8","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1158\/0008-5472.CAN-15-1348","volume":"76","author":"VR Mittapalli","year":"2016","unstructured":"Mittapalli VR, Madl J, L\u00f6ffek S, Kiritsi D, Kern JS, R\u00f6mer W, et al. Injury-driven stiffening of the dermis expedites skin carcinoma progression. Cancer Res. 2016;76:940\u201351. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1348.","journal-title":"Cancer Res"},{"key":"437_CR9","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.jid.2017.07.002","volume":"137","author":"V Alexeev","year":"2017","unstructured":"Alexeev V, Salas-Alanis JC, Palisson F, Mukhtarzada L, Fortuna G, Uitto J, South A, Igoucheva O. Pro-inflammatory chemokines and cytokines dominate the blister fluid molecular signature in patients with epidermolysis bullosa and affect leukocyte and stem cell migration. J Invest Dermatol. 2017;137:2298\u2013308.","journal-title":"J Invest Dermatol"},{"key":"437_CR10","doi-asserted-by":"publisher","first-page":"e14392","DOI":"10.15252\/emmm.202114392","volume":"13","author":"R Bernasconi","year":"2021","unstructured":"Bernasconi R, Thriene K, Romero-Fern\u00e1ndez E, Gretzmeier C, K\u00fchl T, Maler M, Nauroy P, Kleiser S, R\u00fchl-Muth A-C, Stumpe M, et al. Pro-inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang-(1\u20137). EMBO Mol Med. 2021;13:e14392.","journal-title":"EMBO Mol Med"},{"issue":"18","key":"437_CR11","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1242\/jcs.114.18.3285","volume":"114","author":"V Dugina","year":"2001","unstructured":"Dugina V, Fontao L, Chaponnier C, Vasiliev J, Gabbiani G. Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci. 2001;114(18):3285\u201396. https:\/\/doi.org\/10.1242\/jcs.114.18.3285.","journal-title":"J Cell Sci"},{"issue":"7","key":"437_CR12","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ajpath.2017.03.003","volume":"187","author":"F Cianfarani","year":"2017","unstructured":"Cianfarani F, Zambruno G, Castiglia D, Odorisio T. Pathomechanisms of altered Wound Healing in recessive Dystrophic Epidermolysis Bullosa. Am J Pathol. 2017;187(7):1445\u201353. https:\/\/doi.org\/10.1016\/j.ajpath.2017.03.003.","journal-title":"Am J Pathol"},{"issue":"12","key":"437_CR13","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/ddg.12839","volume":"13","author":"L Boltzmann","year":"2015","unstructured":"Boltzmann L, Gruber C, Klausegger A, Trost A, Bogner B, Reitsamer H, Bauer JW. Pseudosyndactyly-an inflammatory and fibrotic wound healing disorder in recessive dystrophic epidermolysis bullosa. JDDG - Journal of the German Society of Dermatology. 2015;13(12):1257\u201366. https:\/\/doi.org\/10.1111\/ddg.12839.","journal-title":"JDDG - Journal of the German Society of Dermatology"},{"key":"437_CR14","doi-asserted-by":"crossref","unstructured":"Annicchiarico, G., Morgese, M. G., Esposito, S., Lopalco, G., Lattarulo, M., Tampoia,M., \u2026 Iannone, F. (2015). Proinflammatory cytokines and anti skin autoantibodies in patients with inherited epidermolysis bullosa. Medicine (United States), 94(42), e1528.https:\/\/doi.org\/10.1097\/MD.0000000000001528.","DOI":"10.1097\/MD.0000000000001528"},{"issue":"4","key":"437_CR15","first-page":"340","volume":"14","author":"M Tampoia","year":"2017","unstructured":"Tampoia M, Abbracciavento L, Morrone M, Fumarulo R. IL-6\/IL-10 ratio as a prognostic and predictive marker of the severity of inherited epidermolysis Bullosa. Iran J Immunol. 2017;14(4):340\u20139. https:\/\/doi.org\/IJIv14i4A8.","journal-title":"Iran J Immunol"},{"issue":"5","key":"437_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/BIOMEDICINES8050101","volume":"8","author":"BZ Johnson","year":"2020","unstructured":"Johnson BZ, Stevenson AW, Pr\u00eale CM, Fear MW, Wood FM. The role of IL-6 in skin fibrosis and cutaneous wound healing. Biomedicines. 2020;8(5):1\u201318. https:\/\/doi.org\/10.3390\/BIOMEDICINES8050101.","journal-title":"Biomedicines"},{"issue":"1","key":"437_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0923-1811(95)00418-1","volume":"11","author":"A Tang","year":"1996","unstructured":"Tang A, Gilchrest BA. Regulation of keratinocyte growth factor gene expression in human skin fibroblasts. J Dermatol Sci. 1996;11(1):41\u201350. https:\/\/doi.org\/10.1016\/0923-1811(95)00418-1.","journal-title":"J Dermatol Sci"},{"issue":"December 2018","key":"437_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.rmed.2019.08.003","volume":"156","author":"AP Laddha","year":"2019","unstructured":"Laddha AP, Kulkarni YA. VEGF and FGF-2: promising targets for the treatment of respiratory disorders. Respir Med. 2019;156(December 2018):33\u201346. https:\/\/doi.org\/10.1016\/j.rmed.2019.08.003.","journal-title":"Respir Med"},{"issue":"3","key":"437_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/iwj.12735","volume":"14","author":"C Pang","year":"2017","unstructured":"Pang C, Ibrahim A, Bulstrode NW, Ferretti P. An overview of the therapeutic potential of regenerative medicine in cutaneous wound healing. Int Wound J. 2017;14(3):450\u20139. https:\/\/doi.org\/10.1111\/iwj.12735.","journal-title":"Int Wound J"},{"key":"437_CR20","doi-asserted-by":"crossref","unstructured":"Esposito, S., Guez, S., Orenti, A., Tadini, G., Scuvera, G., Corti, L., \u2026 Principi,N. (2016). Autoimmunity and cytokine imbalance in inherited epidermolysis bullosa.International Journal of Molecular Sciences, 17(10), 1\u201313. https:\/\/doi.org\/10.3390\/ijms17101625.","DOI":"10.3390\/ijms17101625"},{"key":"437_CR21","doi-asserted-by":"crossref","unstructured":"Nguyen, H. H., Shinkuma, S., Hayashi, R., Katsumi, T., Nishiguchi, T., Natsuga, K.,\u2026 Abe, R. (2022). New insight of itch mediators and proinflammatory cytokines in epidermolysis bullosa. Journal of Cutaneous Immunology and Allergy, (January), 78\u201387. https:\/\/doi.org\/10.1002\/cia2.12230.","DOI":"10.1002\/cia2.12230"},{"key":"437_CR22","doi-asserted-by":"crossref","unstructured":"Beilin, A.K., Evtushenko, A.N., Lukyanov, K.D., Murashkin, N.N., Ambarchian, E.T.,Pushkov, A. \u2026 Gurskaya, N.G. (2021). Signatures of Dermal Fibroblasts from RDEB Pediatric Patients. Int J Mol Sci. 22(4): 1792. https:\/\/doi.org\/10.3390%2Fijms22041792.","DOI":"10.3390\/ijms22041792"},{"key":"437_CR23","doi-asserted-by":"crossref","unstructured":"Chen, M., Kasahara, N., Keene, D.R., Chan, L., Hoeffler, W.K., Finlay, D., Barcova,M., Cannon, P.M., \u2026 Woodley, D.T. (2002). Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet. 32(4): 670\u2013675. https:\/\/doi.org\/10.1038\/ng1041.","DOI":"10.1038\/ng1041"},{"key":"437_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/bjd.17840","volume":"181","author":"A Condorelli","year":"2019","unstructured":"Condorelli A, Logli E, Cianfarani F, Teson M, Diociaiuti A, Hachem E, Zambruno M, Castiglia G, D., Odorisio T. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts. Br J Dermatol. 2019;181:1017\u201327. https:\/\/doi.org\/10.1111\/bjd.17840.","journal-title":"Br J Dermatol"},{"key":"437_CR25","doi-asserted-by":"crossref","unstructured":"Georgiadis, C., Syed, F., Petrova, A., Abdul-Wahab, A., Lwin, S.M., Farzaneh, F.,Chan, L., Ghani, S., Fleck, R.A., \u2026 Wei-Li, D. (2016). Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB. Journal of Investigative Dermatology. 136(1): 284\u2013292. https:\/\/doi.org\/10.1038\/jid.2015.364.","DOI":"10.1038\/JID.2015.364"},{"key":"437_CR26","doi-asserted-by":"crossref","unstructured":"Ng, Y.Z., Pourreyron, C., Salas-Alanis, J.C., Dayal, J.H., Cepeda-Valdes, R., Yan,W., Wright, S., Chen, M., Fine, J.D., \u2026 South, A.P. (2012). Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. Cancer Res. 72(14): 3522\u20133534. https:\/\/doi.org\/10.1158\/0008-5472.can-11-2996.","DOI":"10.1158\/0008-5472.CAN-11-2996"},{"key":"437_CR27","doi-asserted-by":"crossref","unstructured":"Von Bischhoffshausen, S., Ivulic, D., Alvarez, P., Schuffeneger, V. C., Idiaquez,J., Fuentes, C., \u2026 Calvo, M. (2017). Recessive dystrophic epidermolysis bullosa results in painful small fibre neuropathy. Brain, 140(5), 1238\u20131251. https:\/\/doi.org\/10.1093\/brain\/awx069.","DOI":"10.1093\/brain\/awx069"},{"issue":"1","key":"437_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/22201173.2010.10872625","volume":"16","author":"J Thomas","year":"2010","unstructured":"Thomas J. Epidermolysis bullosa in children: pathophysiology, anaesthesia and analgesia. South Afr J Anaesth Analgesia. 2010;16(1):12\u20135. https:\/\/doi.org\/10.1080\/22201173.2010.10872625.","journal-title":"South Afr J Anaesth Analgesia"},{"key":"437_CR29","unstructured":"Krane E. (2002). Guidelines for the Anesthetic Management of Epidermolysis Bullosa (EB). Retrieved from https:\/\/ether.stanford.edu\/library\/pediatric_anesthesia\/anesthetictechniques\/guideline-eb.pdf."},{"key":"437_CR30","doi-asserted-by":"publisher","unstructured":"Fuentes I, Guttmann-Gruber C, Tockner B et al. (2020). Cells from discarded dressings differentiate chronic from acute wounds in patients with Epidermolysis Bullosa. Sci Rep 10, 15064 (2020). https:\/\/doi.org\/10.1038\/s41598-020-71794-1.","DOI":"10.1038\/s41598-020-71794-1"},{"issue":"10","key":"437_CR31","doi-asserted-by":"publisher","first-page":"e7475","DOI":"10.1371\/journal.pone.0007475","volume":"4","author":"D Pilling","year":"2009","unstructured":"Pilling D, Fan T, Huang D, Kaul B, Gomer RH. Identificaci\u00f3n of markers that distinguish monocyte-derived fibrocytes from Monocytes, Macrophages, and fibroblasts. PLoS ONE. 2009;4(10):e7475. https:\/\/doi.org\/10.1371\/journal.pone.0007475.","journal-title":"PLoS ONE"},{"issue":"6","key":"437_CR32","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nri2990","volume":"11","author":"R Reikoff","year":"2011","unstructured":"Reikoff R, Bucala R, Herzog E. Fibrocytes: the emerging effector cells in chronic inflammation. Nat Rev Immunol. 2011;11(6):427\u201335. https:\/\/doi.org\/10.1038\/nri2990. PMID: 21597472; PMCID: PMC3599774.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"437_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/icb.1997.68","volume":"75","author":"JG Altin","year":"1997","unstructured":"Altin JG, Sloan EK. The role of CD45 and CD45-associated molecules in T cell activation. Immunol Cell Biol Oct. 1997;75(5):430\u201345. https:\/\/doi.org\/10.1038\/icb.1997.68.","journal-title":"Immunol Cell Biol Oct"},{"key":"437_CR34","doi-asserted-by":"crossref","unstructured":"Waldera-Lupa, D.M., Kalfalah, F., Safferling, K., Boukamp, P., Poschmann, G., Volpi,E., G\u00f6tz-R\u00f6sch, C., \u2026 Krutmann, J. (2015). Characterization of Skin Aging-Associated Secreted Proteins (SAASP) Produced by Dermal Fibroblasts Isolated from Intrinsically Aged Human Skin. Journal of Investigative Dermatology. 135(8): 1954\u20131968. https:\/\/doi.org\/10.1038\/jid.2015.120.","DOI":"10.1038\/jid.2015.120"},{"key":"437_CR35","doi-asserted-by":"crossref","unstructured":"Berberich, B., Thriene, K., Gretzmeir, C., K\u00fchl, T., Bayer, H., Athanasiou, I., Rafei-Shamsabadi,D.A., \u2026 Dengjel, J. (2020). Proteomic Profiling of Fibroblasts Isolated from Chronic Wounds Identifies Disease-Relevant Signaling Pathways. Journal of Investigative Dermatology.140(11): 2280\u20132290. https:\/\/doi.org\/10.1016\/j.jid.2020.02.040.","DOI":"10.1016\/j.jid.2020.02.040"},{"issue":"20","key":"437_CR36","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cell lines in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92(20):9363\u20137. https:\/\/doi.org\/10.1073%2Fpnas.92.20.9363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"437_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-59745-361-5_3","volume":"371","author":"K Itahana","year":"2007","unstructured":"Itahana K, Campisi J, Dimri P. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol. 2007;371:21\u201331. https:\/\/doi.org\/10.1007\/978-1-59745-361-5_3.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"437_CR38","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1038\/jid.2008.114","volume":"128","author":"I Wall","year":"2008","unstructured":"Wall I, Moseley R, Baird D, Kipling D, Giles P, Laffafian I, Price PE, Thomas WD, Stephens P. Fibroblast dysfunction is a key factor in the non-healing of chronic venous Leg Ulcers. J Invest Dermatology. 2008;128(10):2526\u201340. https:\/\/doi.org\/10.1038\/jid.2008.114.","journal-title":"J Invest Dermatology"},{"issue":"24","key":"437_CR39","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1101\/gad.179515.111","volume":"25","author":"T Shimi","year":"2011","unstructured":"Shimi T, Butin-Israeli V, Adam SA, Hamanaka RB, Goldman AE, Lucas CA, Shumaker DK, Kosak ST, Chandel NS, Goldman RD. The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev. 2011;25(24):2579\u201393. https:\/\/doi.org\/10.1101\/gad.179515.111.","journal-title":"Genes Dev"},{"key":"437_CR40","doi-asserted-by":"publisher","unstructured":"Hayflick L. The cell biology of aging. J Invest Dermatol. 1979 Jul;73(1):8\u201314. doi: https:\/\/doi.org\/10.1111\/1523-1747.ep12532752. PMID: 448179.","DOI":"10.1111\/1523-1747.ep12532752"},{"key":"437_CR41","doi-asserted-by":"publisher","unstructured":"Magalh\u00e3es S, Almeida I, Pereira CD, Rebelo S, Goodfellow BJ, Nunes A. The Long-Term Culture of Human Fibroblasts Reveals a Spectroscopic Signature of Senescence. Int J Mol Sci. 2022 May 23;23(10):5830. doi: https:\/\/doi.org\/10.3390\/ijms23105830. PMID: 35628639; PMCID: PMC9146002.","DOI":"10.3390\/ijms23105830"},{"issue":"2","key":"437_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/jid.2008.114","volume":"25","author":"R Driskell","year":"2015","unstructured":"Driskell R, Watt F. Understanding fibroblasts heterogeneity in the skin. Trends Cell Biol. 2015;25(2):92\u20139. https:\/\/doi.org\/10.1038\/jid.2008.114.","journal-title":"Trends Cell Biol"},{"key":"437_CR43","doi-asserted-by":"crossref","unstructured":"Chac\u00f3n-Solano, E., Le\u00f3n, C., D\u00edaz, F., Garc\u00eda-Garc\u00eda, F., Garc\u00eda, M., Esc\u00e1mez, M.J.,Guerrero-Aspizua, S., \u2026 del R\u00edo, M. (2019). Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses. British Journal of Dermatology. 181(3): 512\u2013522. https:\/\/doi.org\/10.1111\/bjd.17698.","DOI":"10.1111\/bjd.17698"},{"issue":"9","key":"437_CR44","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/jid.2014.185","volume":"134","author":"V K\u00fcttner","year":"2014","unstructured":"K\u00fcttner V, Mack C, Gretzmeier C, Bruckner-Tuderman L. Loss of collagen VII is Associated with reduced transglutaminase 2 abundance and activity. J Invest Dermatology. 2014;134(9):2381\u20139. https:\/\/doi.org\/10.1038\/jid.2014.185.","journal-title":"J Invest Dermatology"},{"issue":"2","key":"437_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","volume":"60","author":"J-D Fine","year":"2009","unstructured":"Fine J-D, Johnson L, Weiner M, Li K-P, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986\u20132006. J Am Acad Dermatol. 2009;60(2):203\u201311. https:\/\/doi.org\/10.1016\/j.jaad.2008.09.035.","journal-title":"J Am Acad Dermatol"},{"key":"437_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2017.11.004","volume":"66","author":"CM F\u00f6ll","year":"2018","unstructured":"F\u00f6ll CM, Fahrner M, Gretzmeier C, Thoma K, Biniossek ML, Kiritsi D, Meiss F, Schilling O, N\u00ffstrom A, Kern JS. Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinoma. Matrix Biol. 2018;66:1\u201321. https:\/\/doi.org\/10.1016\/j.matbio.2017.11.004.","journal-title":"Matrix Biol"},{"issue":"9","key":"437_CR47","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/cells9092108","volume":"9","author":"T Aguado","year":"2020","unstructured":"Aguado T, Garc\u00eda M, Garc\u00eda A, Ferrer-Mayorga G, Mart\u00ednez-Santamar\u00eda L, R\u00edo D, Botella M, L.M., S\u00e1nchez-Puelles JM. Raloxifene and n-Acetylcysteine ameliorate TGF-Signalling in fibroblasts from patients with recessive Dominant Epidermolysis Bullosa. Cells. 2020;9(9):2108. https:\/\/doi.org\/10.3390%2Fcells9092108.","journal-title":"Cells"},{"issue":"12","key":"437_CR48","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.3390\/biom10121666","volume":"10","author":"X Shi","year":"2020","unstructured":"Shi X, Young C, Zhou H, Wang X-Y. Transforming growth Factor-\u03b2 signaling in Fibrotic Diseases and Cancer-Associated fibroblasts. Biomolecules. 2020;10(12):1666. https:\/\/doi.org\/10.3390\/biom10121666.","journal-title":"Biomolecules"},{"issue":"6","key":"437_CR49","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jid.2020.10.024","volume":"141","author":"E Akasaka","year":"2021","unstructured":"Akasaka E, Kleiser S, Sengle G, Brucker-Tuderman L, N\u00ffstrom A. Diversity of Mechanisms underlying latent TGF-B activation in recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatology. 2021;141(6):1450\u201360. https:\/\/doi.org\/10.1016\/j.jid.2020.10.024.","journal-title":"J Invest Dermatology"},{"key":"437_CR50","doi-asserted-by":"crossref","unstructured":"Chac\u00f3n-Solano E, Le\u00f3n C, Carretero M, Garc\u00eda M, S\u00e1nchez-Dom\u00ednguez R, Quero F, M\u00e9ndez-Jim\u00e9nez E, Bonafont J, Ruiz-Mezcua B, Esc\u00e1mez MJ, Larcher F, Del R\u00edo M. Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-\u03b2 antagonist and inhibitor of fibrosis. Matrix Biol. 2022 Aug;111:189\u2013206. Epub 2022 Jun 30. PMID: 35779740.","DOI":"10.1016\/j.matbio.2022.06.007"},{"key":"437_CR51","doi-asserted-by":"crossref","unstructured":"Prunotto, M., Bruschi, M., Gunning, P., Gabbiani, G., Weibel, F., Ghiggeri, G. M.,\u2026 Chaponnier, C. (2015). Stable incorporation of \u03b1-smooth muscle actin into stress fibers is dependent on specific tropomyosin isoforms.Cytoskeleton, 72(6), 257\u2013267. https:\/\/doi.org\/10.1002\/cm.21230.","DOI":"10.1002\/cm.21230"},{"issue":"8","key":"437_CR52","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1172\/jci68127","volume":"123","author":"A N\u00ffstrom","year":"2013","unstructured":"N\u00ffstrom A, Velati D, Mittapalli VR, Fritsch A, Kern JS, Bruckner-Tuderman L. Collagen VII plays a dual role in wound healing. J Clin Invest. 2013;123(8):3498\u2013509. https:\/\/doi.org\/10.1172\/jci68127.","journal-title":"J Clin Invest"},{"issue":"6","key":"437_CR53","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.imbio.2011.11.003","volume":"217","author":"M Harutyunyan","year":"2012","unstructured":"Harutyunyan M, Christiansen M, Johansen J, K\u00f8ber L, Torp-Petersen C, Kastrup J. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure. Immunobiology. 2012;217(6):652\u20136. https:\/\/doi.org\/10.1016\/j.imbio.2011.11.003.","journal-title":"Immunobiology"},{"issue":"2","key":"437_CR54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/1055-9965.EPI-05-0011","volume":"15","author":"J Johansen","year":"2006","unstructured":"Johansen J, Vittrup B, Roslind A, Nielsen D, Price P. Serum YKL-40, a new prognostic biomarker in cancer patients? Cancer Epidemiol Biomarkers Prev. 2006;15(2):194\u2013202. https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0011.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"437_CR55","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2217\/fon.09.66","volume":"5","author":"J Johansen","year":"2009","unstructured":"Johansen J, Schultz AN, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol. 2009;5(7):1065\u201382. https:\/\/doi.org\/10.2217\/fon.09.66.","journal-title":"Future Oncol"},{"key":"437_CR56","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00011-013-0698-9","volume":"63","author":"H Tao","year":"2014","unstructured":"Tao H, Yang JJ, Shi KH, Huang C, Zhang L, Lv XW, Li J. The significance of YKL-40 protein in liver fibrosis. Inflamm Res. 2014;63:249\u201354. https:\/\/doi.org\/10.1007\/s00011-013-0698-9.","journal-title":"Inflamm Res"},{"key":"437_CR57","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.3390\/ijms24054668","volume":"24","author":"M Scotece","year":"2023","unstructured":"Scotece M, H\u00e4m\u00e4l\u00e4inen M, Lepp\u00e4nen T, Vuolteenaho K, Moilanen E. MKP-1 Deficiency exacerbates skin fibrosis in a mouse model of Scleroderma. Int J Mol Sci. 2023;24:4668. https:\/\/doi.org\/10.3390\/ijms24054668.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"437_CR58","doi-asserted-by":"publisher","first-page":"e739","DOI":"10.1002\/ctm2.739","volume":"12","author":"YS Lee","year":"2022","unstructured":"Lee YS, Yu JE, Kim MJ, Ham HJ, Jeon SH, Yun J, Song SG, Lee CK, Han SB, Son DJ, Hong JT. New therapeutic strategy for atopic dermatitis by targeting CHI3L1\/ITGA5 axis. Clin translational Med. 2022;12(2):e739. https:\/\/doi.org\/10.1002\/ctm2.739.","journal-title":"Clin translational Med"},{"key":"437_CR59","doi-asserted-by":"publisher","unstructured":"Jankowska-Konsur A, \u0141yko M, Rubas K, Nowicka-Suszko D, Maj J, Szepietowski JC. (2022). Chitinase-3-like Protein 1 (YKL-40): A New Biomarker of Inflammation in Pyoderma Gangrenosum. Acta dermato-venereologica, 102, adv00646. https:\/\/doi.org\/10.2340\/actadv.v101.978.","DOI":"10.2340\/actadv.v101.978"},{"issue":"4","key":"437_CR60","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/03009740510018598","volume":"34","author":"C Nordenb\u00e6k","year":"2005","unstructured":"Nordenb\u00e6k C, Johansen JS, Halberg P, Wiik A, Garbarsch C, Ullman S, Price PA, Jacobsen S. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol. 2005;34(4):293\u20137. https:\/\/doi.org\/10.1080\/03009740510018598.","journal-title":"Scand J Rheumatol"},{"key":"437_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bbacli.2013.12.001","volume":"1","author":"YY Ho","year":"2014","unstructured":"Ho YY, Baron M, Recklies AD, Roughley PJ, Mort JS. Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1. BBA Clin. 2014;1:2\u201311. https:\/\/doi.org\/10.1016\/j.bbacli.2013.12.001.","journal-title":"BBA Clin"},{"key":"437_CR62","doi-asserted-by":"crossref","unstructured":"Atanasova VS, Russell RJ, Webster TG, Cao Q, Agarwal P, Lim YZ, Krishnan S, Fuentes I, Guttmann-Gruber C, McGrath JA, Salas-Alanis JC, Fertala A, South AP. Thrombospondin-1 Is a Major Activator of TGF-\u03b2 Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts. J Invest Dermatol 2019 Jul;139(7):1497\u20131505e5. doi: 10.1016\/j.jid.2019.01.011. Epub 2019 Jan 23. PMID: 30684555.","DOI":"10.1016\/j.jid.2019.01.011"},{"key":"437_CR63","doi-asserted-by":"crossref","unstructured":"Odorisio, T., Di Salvio, M., Orecchia, A., Di Zenzo, G., Piccini, E., Cianfarani,F., Travaglione, A., Uva, P. &, \u2026 Castiglia, D. (2014). Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-B signalling in modifying disease severity. Human Molecular Genetics. 23(15): 3907\u20133922.https:\/\/doi.org\/10.1093\/hmg\/ddu102.","DOI":"10.1093\/hmg\/ddu102"},{"key":"437_CR64","doi-asserted-by":"crossref","unstructured":"Bolivar, S., Espitia-Corredor, J.A., Olivares-Silva, F., Valenzuela, P., Humeres,C., Anfossi, R., Castro, E. \u2026 D\u00edaz-Araya, G. (2021). In cardiac fibroblasts, interferon-beta attenuates differentiation, collagen synthesis, and TGF-\u03b21-induced collagen gel contraction. Cytokine. 138, 155359. https:\/\/doi.org\/10.1016\/j.cyto.2020.155359.","DOI":"10.1016\/j.cyto.2020.155359"},{"issue":"10","key":"437_CR65","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1128\/mcb.8.10.4162-4168.1988","volume":"8","author":"LE Gentry","year":"1988","unstructured":"Gentry LE, Lioubin MN, Purchio AF, Marquardt H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol. 1988;8(10):4162\u20138. https:\/\/doi.org\/10.1128\/mcb.8.10.4162-4168.1988.","journal-title":"Mol Cell Biol"},{"key":"437_CR66","doi-asserted-by":"publisher","first-page":"21364","DOI":"10.1038\/s41598-020-78206-4","volume":"10","author":"SW Clayton","year":"2020","unstructured":"Clayton SW, Ban GI, Liu C, et al. Canonical and noncanonical TGF-\u03b2 signaling regulate fibrous tissue differentiation in the axial skeleton. Sci Rep. 2020;10:21364. https:\/\/doi.org\/10.1038\/s41598-020-78206-4.","journal-title":"Sci Rep"},{"issue":"3","key":"437_CR67","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/JLB.2MR0717-310R","volume":"103","author":"DA Covino","year":"2018","unstructured":"Covino DA, Gauzzi MC, Fantuzzi L. Understanding the regulation of APOBEC3 expression: current evidence and much to learn. J Leukoc Biol. 2018;103(3):433\u201344. https:\/\/doi.org\/10.1002\/JLB.2MR0717-310R.","journal-title":"J Leukoc Biol"},{"issue":"November","key":"437_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.768098","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, Deng Y, Li Z, Chen Y, Zhu X, Tan X, Cao G. Cancer Evo\u2013Dev: a theory of Inflammation-Induced Oncogenesis. Front Immunol. 2021;12(November):1\u201313. https:\/\/doi.org\/10.3389\/fimmu.2021.768098.","journal-title":"Front Immunol"},{"key":"437_CR69","doi-asserted-by":"crossref","unstructured":"Cho, R. J., Alexandrov, L. B., Den Breems, N. Y., Atanasova, V. S., Farshchian, M.,Purdom, E., \u2026 South, A. P. (2018). APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Science Translational Medicine, 10(455), 1\u201312. https:\/\/doi.org\/10.1126\/scitranslmed.aas9668.","DOI":"10.1016\/j.jid.2017.07.734"},{"key":"437_CR70","doi-asserted-by":"crossref","unstructured":"Li, S., Bao, X., Wang, D., You, L., Li, X., Yang, H., \u2026 Yang, Y. (2017). APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells. Science China Life Sciences, 60(6), 617\u2013626. https:\/\/doi.org\/10.1007\/s11427-016-9058-6.","DOI":"10.1007\/s11427-016-9058-6"},{"key":"437_CR71","doi-asserted-by":"crossref","unstructured":"Fuentes, I., Yubero, M. J., Morand\u00e9, P., Varela, C., Or\u00f3stica, K., Acevedo, F., \u2026Palisson, F. (2022). Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients. International Wound Journal, 2022(July), 1\u201310. https:\/\/doi.org\/10.1111\/iwj.13922.","DOI":"10.1111\/iwj.13922"},{"issue":"6","key":"437_CR72","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1067\/mva.2001.115379","volume":"33","author":"A Stanley","year":"2001","unstructured":"Stanley A, Osler T. Senescence and the healing rates of venous ulcers. J Vasc Surg. 2001;33(6):1206\u201311. https:\/\/doi.org\/10.1067\/mva.2001.115379.","journal-title":"J Vasc Surg"},{"key":"437_CR73","doi-asserted-by":"crossref","unstructured":"Capparelli, C., Guido, C., Whitaker-Menezes, D., Bonuccelli, G., Balliet, R., Pestell,T. G., \u2026 Lisanti, M. P. (2012). Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis, via glycolysis and ketone production.Cell Cycle, 11(12), 2285\u20132302. https:\/\/doi.org\/10.4161\/cc.20718.","DOI":"10.4161\/cc.20718"},{"key":"437_CR74","doi-asserted-by":"crossref","unstructured":"Alimirah, F., Pulido, T., Valdovinos, A., Alptekin, S., Chang, E., Jones, E., \u2026 Campisi,J. (2020). Cellular senescence promotes skin carcinogenesis through p38MAPK and p44\/42MAPK signaling. Cancer Research, 80(17), 3606\u20133619. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0108.","DOI":"10.1158\/0008-5472.CAN-20-0108"},{"key":"437_CR75","doi-asserted-by":"crossref","unstructured":"Farsam, V., Basu, A., Gatzka, M., Treiber, N., Schneider, L. A., Mulaw, M. A., \u2026 Scharffetter-Kochanek,K. (2016). Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration. Oncotarget, 7(50), 83554\u201383569. https:\/\/doi.org\/10.18632\/oncotarget.13446.","DOI":"10.18632\/oncotarget.13446"},{"key":"437_CR76","doi-asserted-by":"publisher","unstructured":"Tartaglia G, Cao Q, Padron ZM, South AP. Impaired wound healing, fibrosis, and cancer: the paradigm of recessive dystrophic epidermolysis bullosa. Int J Mol Sci. 2021;22(10). https:\/\/doi.org\/10.3390\/ijms22105104.","DOI":"10.3390\/ijms22105104"},{"key":"437_CR77","doi-asserted-by":"crossref","unstructured":"Roberts, S. A., Lawrence, M. S., Klimczak, L. J., Grimm, S. A., Fargo, D., Stojanov,P., \u2026 Gordenin, D. A. (2013). An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nature Genetics, 45(9), 970\u2013976. https:\/\/doi.org\/10.1038\/ng.2702.","DOI":"10.1038\/ng.2702"},{"issue":"5","key":"437_CR78","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/0963689717725755","volume":"27","author":"S Zhang","year":"2018","unstructured":"Zhang S, Duan E. Fighting against skin aging: the way from Bench to Bedside. Cell Transplant. 2018;27(5):729\u201338. https:\/\/doi.org\/10.1177\/0963689717725755.","journal-title":"Cell Transplant"},{"key":"437_CR79","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1242\/jcs.01005","volume":"5","author":"JM Sorrell","year":"2004","unstructured":"Sorrell JM, Caplan AI. Fibroblast heterogeneity: more than skin deep. J cell Sci 117(Pt. 2004;5:667\u201375. https:\/\/doi.org\/10.1242\/jcs.01005.","journal-title":"J cell Sci 117(Pt"},{"key":"437_CR80","doi-asserted-by":"publisher","unstructured":"Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.), 25(4), 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262.","DOI":"10.1006\/meth.2001.1262"},{"issue":"3","key":"437_CR81","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/bjd.13737","volume":"173","author":"ES Gorell","year":"2015","unstructured":"Gorell ES, Nguyen N, Siprashvili Z, Marinkovich MP, Lane AT. Characterization 394 of patients with dystrophic epidermolysis bullosa for collagen VII therapy. Br J Dermatol Sep. 2015;173(3):821\u20133. https:\/\/doi.org\/10.1111\/bjd.13737.","journal-title":"Br J Dermatol Sep"},{"issue":"7 July","key":"437_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0232565","volume":"15","author":"A Suarez-Arnedo","year":"2020","unstructured":"Suarez-Arnedo A, Figueroa FT, Clavijo C, Arbel\u00e1ez P, Cruz JC, Mu\u00f1oz-Camargo C. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS ONE. 2020;15(7 July):1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0232565.","journal-title":"PLoS ONE"},{"key":"437_CR83","doi-asserted-by":"publisher","unstructured":"Ngo P, Ramalingam P, Phillips JA, Furuta GT, Clifton NJ.), 341, 103\u2013109. https:\/\/doi.org\/10.1385\/1-59745-113-4:103.","DOI":"10.1385\/1-59745-113-4:103"},{"key":"437_CR84","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.cellbio.042308.11331","volume":"26","author":"F Grinnell","year":"2010","unstructured":"Grinnell F, Petroll WM. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev Biol. 2010;26:335\u201361. https:\/\/doi.org\/10.1146\/annurev.cellbio.042308.11331.","journal-title":"Annu Rev Cell Dev Biol"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-023-00437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-023-00437-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-023-00437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T04:44:27Z","timestamp":1683693867000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-023-00437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1186\/s40659-023-00437-2","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Cl\u00ednica Alemana-Universidad del Desarrollo #2013\u2009\u2212\u2009145. Whereas, written informed consent was obtained from each patient prior to sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}